Press Release

View printer-friendly version << Back
Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015

BOSTON, May 21, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("the Company"), a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health, today announced that CEO Frank Condella will present at the Jefferies 2015 Global Healthcare Conference as follows:

Date:

Thursday, June 4, 2015

Time:

1:00 PM EDT

Location:

New York, NY

Webcast (live & archive):

www.juniperpharma.com, under  'Investor' or click here

The webcast presentation will be archived for 90 days via the aforementioned URLs.

About Juniper Pharmaceuticals

Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) (formerly Columbia Laboratories) is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health. Juniper has a successful heritage in developing pharmaceutical products, including CRINONE® 8% (progesterone gel), which is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 countries worldwide. The Company is leveraging in-house pharmaceutical development, clinical trial manufacturing, and analytical capabilities to advance an internal development pipeline, while also providing valuable consultative services to its pharmaceutical industry customers. Please visit www.juniperpharma.com for more information.

Juniper Pharmaceuticals™ and Juniper Pharma Services™ are trademarks of Juniper Pharmaceuticals, Inc., in the U.S. and EU.

CRINONE® is a registered trademark of Actavis, Inc. in the U.S.

Contact
Katja Buhrer, MBS Value Partners
(212) 661-7004
katja.buhrer@mbsvalue.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-present-at-jefferies-2015-global-healthcare-conference-on-june-4-2015-300087054.html

SOURCE Juniper Pharmaceuticals, Inc.